Andrew Murphy - EVP Research at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Research
Stock Symbol
REGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Andrew Murphy - trading volume in the past year for Regeneron Pharmaceuticals, Inc.

Holdings reported by Andrew Murphy for Regeneron Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 48,306 $46.8 M $968.20 Mar 14, 2024 Direct
Common Stock 4,310 $4.17 M $968.20 Mar 13, 2024 By 401(k) Plan
Non-Qualified Stock Option (right to buy) 20,000 Mar 13, 2024 Direct Common Stock

Transactions reported by Andrew Murphy for Regeneron Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership